Cargando…

GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumors in the digestive system. A greater understanding of the pathogenesis of PDAC may facilitate the search for new therapeutic targets. Guanine nucleotide‐binding protein subunit gamma‐12 (GNG12) belongs to the G protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juan, Jin, Can, Zou, Chuanxin, Qiao, Xu, Ma, Peng, Hu, Di, Li, Wenqin, Jin, Jun, Jin, Xin, Fan, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996305/ https://www.ncbi.nlm.nih.gov/pubmed/31898405 http://dx.doi.org/10.1002/2211-5463.12784

Ejemplares similares

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma
por: Wang, Yuqiong, et al.
Publicado: (2021)

GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses
por: Zhang, Youfu, et al.
Publicado: (2021)

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma
por: Ding, Jinsheng, et al.
Publicado: (2021)

GNG4 Promotes Tumor Progression in Colorectal Cancer
por: Liang, Liang, et al.
Publicado: (2021)

Lymph node ratio predicts prognosis in patients with surgically resected invasive pancreatic cystic neoplasms
por: Jin, Can, et al.
Publicado: (2020)

PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
por: Azad, Abul, et al.
Publicado: (2016)

The Prognostic Value of GNG7 in Colorectal Cancer and Its Relationship With Immune Infiltration
por: Fang, Can, et al.
Publicado: (2022)

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022)

Circular RNA expression in pancreatic ductal adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2019)

High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
por: Zhou, Bodong, et al.
Publicado: (2021)

PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1
por: Ye, Zhihua, et al.
Publicado: (2022)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Yu, Shuang-Ni, et al.
Publicado: (2016)

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
por: Kang, Chang Moo, et al.
Publicado: (2007)

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma
por: Zhang, Yiyin, et al.
Publicado: (2019)

GNG4, as a potential predictor of prognosis, is correlated with immune infiltrates in colon adenocarcinoma
por: Wang, Juan, et al.
Publicado: (2023)

Restored CD8(+)PD-1(+) T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma
por: Zhu, Qian, et al.
Publicado: (2022)

The Expressions of NF−κB, COX−2, Sp1, and c−Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival
por: Renaldi, Kaka, et al.
Publicado: (2023)

Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma
por: Vaz, Arokia Priyanka, et al.
Publicado: (2015)

Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
por: Kim, Hongbeom, et al.
Publicado: (2020)

NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma
por: Ramakrishnan, Gopalakrishnan, et al.
Publicado: (2022)

Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma
por: Yuan, Jinghong, et al.
Publicado: (2021)

Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma
por: Liu, Jing, et al.
Publicado: (2019)

Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
por: Gao, Jun, et al.
Publicado: (2013)

Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
por: Li, Junjie, et al.
Publicado: (2016)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
por: Zhang, Yue, et al.
Publicado: (2022)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
por: Thakur, Gitika, et al.
Publicado: (2021)

Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma
por: Huang, Can, et al.
Publicado: (2019)

PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway
por: Tang, Dong, et al.
Publicado: (2017)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)

Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma
por: Wang, Yuqiong, et al.
Publicado: (2016)

Oral mycobiota and pancreatic ductal adenocarcinoma
por: Wei, Ailin, et al.
Publicado: (2022)

Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma
por: Zhu, Zhi-gang, et al.
Publicado: (2022)

Comparative Proteomic Profiling of Pancreatic Ductal Adenocarcinoma Cell Lines
por: Kim, Yikwon, et al.
Publicado: (2014)

Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma
por: Burrack, Adam L., et al.
Publicado: (2019)

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eav9cde653ajnb64jjdflboodo